A.R. Mays recently began work at Celgene, a global biopharmaceutical company. The Phoenix location is a state-of-the-art sterile pharmaceutical manufacturing facility that produces a line of nanotechnology oncology products. The two-phase project will focus on improvements to work and people flow to the 10,000 SF facility. Work is scheduled to be completed in winter of 2018.